The trademark C the signs was filed by C the Signs Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on May 6, 2024, and received one opposition filed on July 30, 2024 by CLARIANE on Likelihood of confusion. the opponent was represented by SCAN AVOCATS and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued July 30, 2024
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).
Change of name and address of the trademark registration was recorded on October 18, 2023.
Goods And Services
The mark was filed in class 9 with following description of goods:
Artificial intelligence software for healthcare
Software
Software applications
Application software
Computer software
Smartphone software
Computer software platforms, recorded or downloadable
Mobile application software
Digital media, namely, downloadable audio and audiovisual recordings
Multi-platform digital tools
All of the aforesaid goods for use in relation to and relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients.
The mark was filed in class 35 with following description of goods:
Data processing services in the field of healthcare
Data management
Data processing
Database management
Data entry and data processing
Compilation of data
Automated data processing
Data collection services
Systematization of data in computer databases
Collating of data in computer databases
Market research data analysis
Online data processing services
Preparation of healthcare statistical data
Data and database improvement, namely, compiling, reviewing and processing data for the purposes of improving cancer risk assessment, cancer diagnosis, cancer treatment and assessment of clinical needs of cancer patients
Data and database enhancement, namely, compiling, reviewing and processing data for the purposes of enhancing cancer risk assessment, cancer diagnosis, cancer treatment and assessment of clinical needs of cancer patients
Combining data from multiple sources into databases
Information, advisory and consultancy services relating to all of the aforesaid
All of the aforesaid services relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients.
The mark was filed in class 41 with following description of goods:
Educational and training services relating to healthcare
Education
Providing of training
Teaching
Arranging and conducting of conferences, seminars and training workshops
Correspondence courses
Educational services
Vocational guidance
Organisation of exhibitions for educational purposes
Providing on-line electronic publications
Information, advisory and consultancy services relating to all of the aforesaid
All of the aforesaid services relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients.
The mark was filed in class 42 with following description of goods:
Information technology services for the pharmaceutical and healthcare industries
Providing online, non-downloadable software, software as a service (SaaS), platform as a service (PaaS) and online, non-downloadable software platforms
Information, advisory and consultancy services relating to all of the aforesaid
All of the aforesaid services relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients.
The mark was filed in class 44 with following description of goods:
Healthcare
Medical services
Hospitals and medical clinics
Medical assistance
Nursing
Health screening services
Dissemination of data relating to healthcare
Information, advisory and consultancy services relating to all of the aforesaid
All of the aforesaid services relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients.